SECsense Logo

180 Life Sciences Corp. 8-K Filing Report: Key Financial Insights

$ATNF
Form 8-K
Filed on: 2024-12-31
Source
180 Life Sciences Corp. 8-K Filing Report: Key Financial Insights

Based on the provided section of the financial report, here are the key insights and information extracted:

  1. Entity Identification:
  • Company Name: 180 Life Sciences Corp.
  • CIK Number: 0001690080
  • SEC File Number: 001-38105
  • EIN: 90-1890354
  • Address: 3000 El Camino Real, Building 4, Suite 200, Palo Alto, CA 94306
  • Phone Number: 650-507-0669
  1. Report Type:
  • The report type is an 8-K filing, which is typically used for reporting major events that shareholders should know about.
  1. Date of Filing:
  • The report was filed on December 27, 2024.
  1. Stock Information:
  • Common Stock: The par value of the common stock is $0.0001 per share.
  • Warrants: There are warrants to purchase shares of common stock, identified with the ticker symbol ATNFW, listed on NASDAQ.
  1. Financial Reporting Context:
  • The reporting period specified is as of December 27, 2024.
  • The context indicates that the financial statements include information relevant to both common stock and warrants.
  1. Measurement Units:
  • Financial data is reported in USD (U.S. Dollars) and shares.
  1. Regulatory Compliance:
  • The document adheres to XBRL (eXtensible Business Reporting Language) standards, which is a requirement for SEC filings to facilitate data analysis and reporting.

This summary highlights the essential components of the financial report, focusing on the company's identification, stock details, and compliance with regulatory requirements.